JP2022547231A5 - - Google Patents
Info
- Publication number
- JP2022547231A5 JP2022547231A5 JP2022539453A JP2022539453A JP2022547231A5 JP 2022547231 A5 JP2022547231 A5 JP 2022547231A5 JP 2022539453 A JP2022539453 A JP 2022539453A JP 2022539453 A JP2022539453 A JP 2022539453A JP 2022547231 A5 JP2022547231 A5 JP 2022547231A5
- Authority
- JP
- Japan
- Prior art keywords
- pnpp
- pharmaceutical product
- eye
- composition
- neuropathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962895252P | 2019-09-03 | 2019-09-03 | |
| US62/895,252 | 2019-09-03 | ||
| US17/008,794 US20210060125A1 (en) | 2019-09-03 | 2020-09-01 | METHOD AND USE OF PnPP-19 FOR PREVENTING AND TREATING EYE DISEASES |
| US17/008,794 | 2020-09-01 | ||
| PCT/BR2020/050349 WO2021042193A1 (en) | 2019-09-03 | 2020-09-01 | Method and use of pnpp-19 for preventing and treating eye diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022547231A JP2022547231A (ja) | 2022-11-10 |
| JP2022547231A5 true JP2022547231A5 (enExample) | 2023-09-01 |
Family
ID=74682721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539453A Pending JP2022547231A (ja) | 2019-09-03 | 2020-09-01 | 眼疾患の予防および処置のための方法およびＰｎＰＰ－１９の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210060125A1 (enExample) |
| EP (1) | EP4025234A4 (enExample) |
| JP (1) | JP2022547231A (enExample) |
| KR (1) | KR20220084011A (enExample) |
| CN (1) | CN114302734A (enExample) |
| BR (1) | BR112022003759A2 (enExample) |
| CA (1) | CA3147704A1 (enExample) |
| WO (1) | WO2021042193A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR131863A1 (es) * | 2023-02-17 | 2025-05-07 | Biozeus Biopharmaceuticals S A | Formulación peptídica tópica para el tratamiento de la disfunción sexual |
| WO2025133214A1 (en) | 2023-12-21 | 2025-06-26 | Novaliq Gmbh | Ophthalmic polypeptide compositions for the treatment of posterior eye disorders |
| CN118985527B (zh) * | 2024-09-04 | 2026-05-01 | 首都医科大学附属北京同仁医院 | 一种无须眼部干预的病理性近视动物模型建立方法和用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005097137A (ja) * | 2003-09-22 | 2005-04-14 | Tokyoto Igaku Kenkyu Kiko | 糖尿病性網膜症の予防又は治療剤 |
| JP2011219412A (ja) * | 2010-04-09 | 2011-11-04 | Saisentan Igaku Kenkyusho:Kk | 緑内障の視野改善治療薬 |
| US8759298B2 (en) * | 2010-05-03 | 2014-06-24 | Scott & White Healthcare | Protein therapy for corneal inflammation, epithelial wound healing, and photoreceptor degeneration |
| US9279004B2 (en) * | 2012-08-20 | 2016-03-08 | Universidade Federal De Minas Gerais—Ufmg | Synthetic PnTx(19) peptide, pharmaceutical compositions and use |
| GB201401453D0 (en) * | 2014-01-28 | 2014-03-12 | Univ Birmingham | Transmucosal and transepithelial drug delivery system |
| BR102014010268B1 (pt) * | 2014-04-29 | 2021-12-28 | Universidade Federal De Minas Gerais - Ufmg | Uso do peptídeo sintético pntx-19 para tratamento de dor |
| WO2017068388A2 (pt) * | 2015-09-18 | 2017-04-27 | Universidade Federal De Minas Gerais - Ufmg | Uso do peptideo sintetico pntx-19 para tratamento de dor |
-
2020
- 2020-09-01 CA CA3147704A patent/CA3147704A1/en active Pending
- 2020-09-01 WO PCT/BR2020/050349 patent/WO2021042193A1/en not_active Ceased
- 2020-09-01 KR KR1020227006863A patent/KR20220084011A/ko not_active Abandoned
- 2020-09-01 CN CN202080061721.7A patent/CN114302734A/zh active Pending
- 2020-09-01 EP EP20860001.5A patent/EP4025234A4/en not_active Withdrawn
- 2020-09-01 US US17/008,794 patent/US20210060125A1/en not_active Abandoned
- 2020-09-01 JP JP2022539453A patent/JP2022547231A/ja active Pending
- 2020-09-01 BR BR112022003759A patent/BR112022003759A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Casson | Medical therapy for glaucoma: A review | |
| KR102017916B1 (ko) | 노안, 경도 원시 및 불규칙한 난시의 치료를 위한 조성물 및 방법 | |
| EP2755647B1 (en) | Use of omega fatty acids for treating disease | |
| JP2008538215A5 (enExample) | ||
| JP2006524185A5 (enExample) | ||
| JPH069383A (ja) | Ｎ−アセチル−システイン及びポリビニルアルコールを含有する眼医薬組成物 | |
| JP6014033B2 (ja) | 防腐剤無添加ビマトプロストおよびチモロール溶液 | |
| EP2512230A1 (en) | Non-irritating ophthalmic povidone-iodine compositions | |
| JP2024103501A (ja) | 被験体における虚血再灌流障害のリスクを予防又は軽減するための神経保護特性がある薬物の使用 | |
| JP2022554277A5 (enExample) | ||
| JP2019507758A5 (enExample) | ||
| JP2021102626A5 (enExample) | ||
| JP2021046394A5 (enExample) | ||
| JP2022530471A5 (enExample) | ||
| WO2018074421A1 (ja) | 眼科用剤及び眼科用薬 | |
| CN116785290B (zh) | 苯环喹溴铵及其异构体在制备眼用制剂中的应用 | |
| CN106999452B (zh) | 前列腺素类和一氧化氮供体的组合产品 | |
| WO2019024433A1 (zh) | 氨基金刚烷胺单硝酸酯类化合物眼用组合物及其制剂和应用 | |
| HURWITZ et al. | Uses of naphazoline (privine®) in ophthalmology | |
| CN102210683B (zh) | 四氢嘧啶及衍生物在制备预防和治疗青光眼药物中的应用 | |
| TW201705956A (zh) | 唑系抗真菌藥之對眼瞼皮膚的投與 | |
| US10905695B2 (en) | Ophthalmic composition for lowering intraocular pressure | |
| RU2633054C1 (ru) | Фармацевтическая композиция в виде геля для лечения блефаритов | |
| TW202345853A (zh) | 無防腐劑的眼科藥物乳劑及其應用 | |
| CN110327350B (zh) | 多巴胺d1受体拮抗剂sch39166在作为制备治疗眼部病理性血管新生药物的应用 |